Biotech News

GSK enters exclusive collaboration with SBP Group, a market leader in hepatology in China, to accelerate bepirovirsen at launch

GSK plc (GSK)GSK plc2026-06-25 13:46 ESTPartnership

Bepirovirsen is a potential first-in-class treatment for chronic hepatitis B, under priority regulatory review in China

Open original release

Related news

GSKGSK plc2026-06-25 13:46 EST

GSK announces commencement of tender offer to acquire Nuvalent, Inc.

GSKGSK plc2026-06-25 13:46 EST

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

GSKGSK plc2026-06-25 13:46 EST

GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome

GSKGSK plc2026-06-25 13:46 EST

GSK enters agreement to acquire Nuvalent, Inc.

GSKGSK plc2026-06-25 13:46 EST

Bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B

GSKGSK plc2026-06-25 13:46 EST

GSK to showcase long-term outcomes and pipeline expansion with latest oncology research at ASCO and EHA

GSKGSK plc2026-06-25 13:46 EST

GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk

GSKGSK plc2026-06-25 13:46 EST

GSK and Xenoport resubmit new drug application for Solzira™ in restless legs syndrome

GSKGSK plc2026-06-25 13:46 EST

GlaxoSmithKline receives European Commission approval to market alli® (orlistat 60mg)

GSKGSK plc2026-06-25 13:46 EST

GSK’s paediatric pneumococcal candidate vaccine Synflorix™ receives positive opinion in Europe

View all latest news

GSK plc

GSK plc is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

GSKGSK plc2026-06-26 06:02 EST

GSK announces commencement of tender offer to acquire Nuvalent, Inc.

GSKGSK plc2026-06-26 06:02 EST

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

GSKGSK plc2026-06-26 06:02 EST

GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome

GSKGSK plc2026-06-26 06:02 EST

GSK enters agreement to acquire Nuvalent, Inc.

GSKGSK plc2026-06-26 06:02 EST

Bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B

Stock data

Close: —
Market cap: —
Exchange: NYSE
Sector: Biotechnology
Location: United States